Trial Search Results
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.
Stanford is currently accepting patients for this trial.
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
- South Asian
Exclusion Criteria:
- Pregnant women
- Patients with prior diagnoses of diabetes
- Patients on insulin therapy
- Patients with known coronary heart disease or other non-ischemic cardiomyopathies
Ages Eligible for Study
20 Years - 60 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Krystal Solis
650-723-8138
Recruiting